The newly revised BS EN ISO 11137-1:2026 standard represents a significant step forward in ensuring the safety and effectiveness of medical devices through rigorous radiation sterilization processes.

The publication of BS EN ISO 11137-1:2026 Sterilization of health care products. Radiation - Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices supports those who conduct radiation sterilizations of medical devices.

This revised document provides comprehensive requirements and guidance for the development, validation, and routine control of radiation sterilization processes, ensuring medical devices are safely and effectively sterilized.

BS EN ISO 11137-1:2026 promotes good practices in the sterilization of medical devices, ensuring that radiation sterilization processes are effectively validated, routinely monitored, and maintained. This not only improves patient safety by preventing infections but also supports manufacturers in meeting regulatory compliance and enhancing the overall reliability of their sterilization processes.

What are the key changes to BS EN ISO 11137-1?

BS EN ISO 11137-1:2026 replaces the 2006 version of the standard. It introduces several critical changes aimed at enhancing the reliability and effectiveness of radiation sterilization processes.

The major updates include:

• Addition of ISO 13004 and ISO/ASTM 52628. These normative references integrate additional best practices for dosimetry in radiation processing, aligning terminology with ASTM standards for consistency.

• Updated common clause 4. Reflecting the latest updates for ISO/TC 198 documents, this revision provides clearer and more unified guidance.

• Increased allowable limits for induced radioactivity. The new limits for assessing potential induced radioactivity are now 11 MeV for electrons and 7.5 MeV for X-rays, addressing advancements in technology and safety standards.

• Enhanced control function requirements. New requirements ensure that a control function failure does not result in an erroneous recording of process parameters, maintaining the integrity of the sterilization process.

• Simplified dose transference content. The revision simplifies the verification of dose transference, based on data showing that operating conditions do not impact microbicidal effectiveness for non-microbial growth-supporting products.

• Clarified process control measurements. The use of dose measurements and recording process variables for process control has been clarified, enhancing transparency and reproducibility.

• Flexible quarterly dose audits. The interval for quarterly dose audits is now more flexible, allowing up to four months between audits, provided there are four audits annually.

• Expanded VDmaxSD references. Additional references for all VDmaxSD dose levels from BS EN ISO 11137-2 and BS EN ISO 13004 ensure comprehensive guidance.

• Bioburden determination guidance. New information on determining bioburden for products with very low bioburden ensures accurate and reliable sterilization validation.

Discover how standards are further supporting medical device manufacturers and end-users by visiting our Medical Devices page.

What are the benefits of using the revised BS EN ISO 11137-1?

By addressing industry challenges, supporting technological advancements, and promoting good practices, BS EN ISO 11137-1:2026 provides a comprehensive framework for manufacturers to achieve and maintain high sterility assurance levels - ultimately benefitting patient safety and regulatory compliance worldwide.

Addressing industry challenges

The revised standard addresses key industry challenges by providing clear and detailed requirements for ensuring the sterility of medical devices.

Manufacturing conditions often allow microorganisms to be present on devices before sterilization, necessitating robust sterilization processes to eliminate these contaminants. The document outlines criteria for achieving reliable and reproducible microbicidal activity, crucial for transforming non-sterile devices into sterile ones.

Enhancing confidence in sterility

By setting stringent validation, routine monitoring, and maintenance requirements, the BS EN ISO 11137-1:2026 enhances confidence in predicting low probabilities of contamination. It acknowledges the variation in regulatory requirements across different countries, ensuring that manufacturers can meet diverse global standards while maintaining high sterility assurance levels.

Supporting technological advancements

The revisions reflect the industry's commitment to evolving technologies and methodologies. By integrating contemporary practices and aligning with international standards, the document supports manufacturers in navigating complex regulatory landscapes and maintaining high standards of quality management in medical device production.

Ensure the reliable radiation sterilization of medical devices, by adopting the newly revised BS EN ISO 11137-1:2026 standard today.